Quanterix (QTRX) Net Income towards Common Stockholders (2017 - 2026)
Quanterix (QTRX) posted Net Income towards Common Stockholders of -$17.5 million for Q1 2026, up 24.12% on a QoQ basis from -$23.1 million in Q4 2025, and up 14.45% year-over-year from -$15.3 million in Q1 2025.
Quanterix (QTRX) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends
Quanterix's Net Income towards Common Stockholders history runs 10 years deep, the most recent figure standing at -$17.5 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 14.45% year-over-year to -$17.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$104.2 million (down 117.64% YoY) and the FY2025 annual result came in at -$107.2 million, down 178.09% from the prior year.
- Net Income towards Common Stockholders was -$17.5 million for Q1 2026 at Quanterix, up from -$23.1 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$5.6 million in Q2 2023 and bottomed at -$36.6 million in Q3 2022.
- A 5-year average of -$17.1 million and a median of -$17.5 million in 2026 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders jumped 81.63% — and 2025, when it slumped 306.29%.
- Quanterix's Net Income towards Common Stockholders stood at -$18.2 million in 2022, then surged by 51.57% to -$8.8 million in 2023, then slumped by 31.94% to -$11.6 million in 2024, then slumped by 98.8% to -$23.1 million in 2025, then advanced by 24.12% to -$17.5 million in 2026.
- Business Quant data shows QTRX's Net Income towards Common Stockholders at -$17.5 million in Q1 2026, -$23.1 million in Q4 2025, and -$33.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Quanterix | 171.71 Mn | 72.44 Mn | 15.57 Mn | -17.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.54 Mn |
| Dec 31, 2025 | -23.12 Mn |
| Sep 30, 2025 | -33.52 Mn |
| Jun 30, 2025 | -30.01 Mn |
| Mar 31, 2025 | -20.50 Mn |
| Dec 31, 2024 | -11.63 Mn |
| Sep 30, 2024 | -8.35 Mn |
| Jun 30, 2024 | -7.39 Mn |
| Mar 31, 2024 | -11.16 Mn |
| Dec 31, 2023 | -8.81 Mn |
| Sep 30, 2023 | -6.72 Mn |
| Jun 30, 2023 | -5.55 Mn |
| Mar 31, 2023 | -7.27 Mn |
| Dec 31, 2022 | -18.20 Mn |
| Sep 30, 2022 | -36.55 Mn |
| Jun 30, 2022 | -26.91 Mn |
| Mar 31, 2022 | -17.92 Mn |
| Dec 31, 2021 | -17.89 Mn |
| Sep 30, 2021 | -15.66 Mn |
| Jun 30, 2021 | -11.90 Mn |